South Korea
· Delayed Price · Currency is KRW Gencurix Statistics
Total Valuation
Gencurix has a market cap or net worth of KRW 28.76 billion. The enterprise value is 31.36 billion.
| Market Cap | 28.76B |
| Enterprise Value | 31.36B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Gencurix has 15.06 million shares outstanding. The number of shares has increased by 35.74% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.06M |
| Shares Change (YoY) | +35.74% |
| Shares Change (QoQ) | +4.06% |
| Owned by Insiders (%) | 15.47% |
| Owned by Institutions (%) | 5.50% |
| Float | 10.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.05 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.50 |
| EV / Sales | 9.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.59 |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.56 |
| Quick Ratio | 0.49 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.08 |
| Interest Coverage | -14.95 |
Financial Efficiency
Return on equity (ROE) is -116.64% and return on invested capital (ROIC) is -27.63%.
| Return on Equity (ROE) | -116.64% |
| Return on Assets (ROA) | -23.02% |
| Return on Capital (ROIC) | -27.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 2.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.11% in the last 52 weeks. The beta is 0.14, so Gencurix's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -62.11% |
| 50-Day Moving Average | 1,738.46 |
| 200-Day Moving Average | 2,590.44 |
| Relative Strength Index (RSI) | 53.45 |
| Average Volume (20 Days) | 742,314 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gencurix had revenue of KRW 3.39 billion and -12.55 billion in losses. Loss per share was -877.76.
| Revenue | 3.39B |
| Gross Profit | 2.11B |
| Operating Income | -10.86B |
| Pretax Income | -13.42B |
| Net Income | -12.55B |
| EBITDA | -9.41B |
| EBIT | -10.86B |
| Loss Per Share | -877.76 |
Balance Sheet
The company has 4.68 billion in cash and 9.48 billion in debt, giving a net cash position of -4.79 billion or -318.39 per share.
| Cash & Cash Equivalents | 4.68B |
| Total Debt | 9.48B |
| Net Cash | -4.79B |
| Net Cash Per Share | -318.39 |
| Equity (Book Value) | 8.51B |
| Book Value Per Share | 701.93 |
| Working Capital | -5.72B |
Cash Flow
In the last 12 months, operating cash flow was -8.28 billion and capital expenditures -463.53 million, giving a free cash flow of -8.74 billion.
| Operating Cash Flow | -8.28B |
| Capital Expenditures | -463.53M |
| Free Cash Flow | -8.74B |
| FCF Per Share | -580.78 |
Margins
| Gross Margin | 62.26% |
| Operating Margin | -319.97% |
| Pretax Margin | -395.51% |
| Profit Margin | n/a |
| EBITDA Margin | -277.26% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Gencurix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.74% |
| Shareholder Yield | -35.74% |
| Earnings Yield | -45.96% |
| FCF Yield | -30.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Gencurix has an Altman Z-Score of -4.72. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.72 |
| Piotroski F-Score | n/a |